Jade Biosciences Inc (NAS:JBIO)
$ 21.73 -0.22 (-1%) Market Cap: 1.32 Bil Enterprise Value: 1.01 Bil PE Ratio: 0 PB Ratio: 3.62 GF Score: 12/100

Jade Biosciences Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 03:30 PM GMT
Release Date Price: $14.12 (-4.79%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

JBIO.OQ - Jade Biosciences Inc
Jade Biosciences Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right, good morning, everyone. Welcome again to TD Cowen's, 46th annual Healthcare Conference. Tyler Van Buren here, senior biotech analyst at TD Cowan.

For next session, I'm very pleased to have a hybrid presentation and fireside chat style Q&A with Jade Biosciences. It's my pleasure to introduce Andrew King, the Chief Scientific scientific Officer of JAD, as well as Brad Doms, the Chief Financial Officer. It's a privilege to have you both here with me. I'll go ahead and hand it over to you to get it started.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot